Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02734134 · ClinicalTrials.gov registry record · NA

One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection

A NA study of Surgical Site Infection, sponsored by OrthoCarolina Research Institute.

Active
Registry status
NA
Development phase
343
Enrollment target
5
Study locations

NCT02734134: Active NA study of Surgical Site Infection, sponsored by OrthoCarolina Research Institute.

NCT02734134 is a NA study of Surgical Site Infection that is active but no longer recruiting, run by OrthoCarolina Research Institute. The registered enrollment target is 343 participants, below the 555-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (38% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02734134, a NA study of Surgical Site Infection, is active but no longer recruiting, sponsored by OrthoCarolina Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
343 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to compare the outcomes of two different treatment options commonly used to manage periprosthetic joint infection (PJI), an infection around the artificial knee or hip.

Primary Outcome

The primary outcome measured will be the recurrence of infection by the same organism or reinfection with a new organism as determined by the criteria using the International Consensus Meeting on PJI (1 year follow-up).

Conditions Studied

Interventions

  • PROCEDURE One-stage exchange joint replacement surgery
  • PROCEDURE Two-stage exchange joint replacement surgery

Study Locations (5)

Illinois

  • Midwest Orthopaedics at Rush University Medical Center - Chicago

New York

  • Hospital for Special Surgery - New York

North Carolina

  • OrthoCarolina Research Institue - Charlotte

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • Rothman Institute at Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 343 participants
Start Date 2016-05-18
Est. Completion 2026-01
Phase NA
OrthoCarolina Research Institute

28 total trials

What the registry record for NCT02734134 still lists

NCT02734134 is an interventional study that assigns participants to a tested intervention. The registered 343 participants enrollment target is mid-sized for trials with a published cap, below the 555-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (38% lower).

The record links to 1 condition, with Surgical Site Infection appearing as the primary indexed condition, and to 2 interventions - of which One-stage exchange joint replacement surgery is the first listed.

NCT02734134 lists 5 locations in 5 states (Illinois, New York, North Carolina).

Frequently Asked Questions

What is clinical trial NCT02734134 about?

NCT02734134 is a clinical study titled "One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection". The purpose of this study is to compare the outcomes of two different treatment options commonly used to manage periprosthetic joint infection (PJI), an infection around the artificial knee or hip.

What is the current status of trial NCT02734134?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 343 participants. The study started on 2016-05-18. Estimated completion is 2026-01.

What conditions does trial NCT02734134 study?

This clinical trial studies the following conditions: Surgical Site Infection.

What interventions are being tested in trial NCT02734134?

The interventions under investigation include: One-stage exchange joint replacement surgery (PROCEDURE), Two-stage exchange joint replacement surgery (PROCEDURE).

Who is sponsoring clinical trial NCT02734134?

This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02734134 being conducted?

This trial has 5 study locations across Illinois, New York, North Carolina, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Site Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02734134's enrollment target sits among peer trials

343 11th of 25 higher than 15 of 25 other Surgical Site Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06733363 · 344 participants · Phase 2

    A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

  • NCT07179380 · 344 participants · Phase 3

    Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • NCT07304024 · 344 participants · Phase 1

    A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

  • NCT05283850 · 342 participants · Phase 2

    Surviving PEA in Roanoke (SPEAR) Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02734134, the US trial registry maintained by the National Library of Medicine. NCT02734134 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.